> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Renews Dermatologic/Ophthalmic Drugs Panel Charter
- URL: https://www.fdaweb.com/fda-renews-dermatologic-ophthalmic-drugs-panel-charter/
- Published: 2018-10-11T12:00:00.000Z
- Updated: 2026-09-15T00:37:31.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142564

*Federal Register* notice: FDA has renewed the charter of its Dermatologic and Ophthalmic Drugs Advisory Committee for an additional two years. The new charter will be in effect until 10/7/2020\. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-10-11/pdf/2018-22183.pdf?ref=fdaweb.com).